3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is growing attracting clinical focus due to limited data suggesting distinct physiological actions. Preliminary research suggest that 3-HPC may 3-Hydroxyphencyclidine display independent effects on the brain structure, arguably playing a role to some of the unanticipated re